Pulmonx Corporation
LUNG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $21,502 | $23,859 | $22,538 | $23,765 |
| % Growth | -9.9% | 5.9% | -5.2% | – |
| Cost of Goods Sold | $5,450 | $6,655 | $6,196 | $6,175 |
| Gross Profit | $16,052 | $17,204 | $16,342 | $17,590 |
| % Margin | 74.7% | 72.1% | 72.5% | 74% |
| R&D Expenses | $4,846 | $5,306 | $4,756 | $4,001 |
| G&A Expenses | $0 | $0 | $0 | $19,106 |
| SG&A Expenses | $25,599 | $26,702 | $26,149 | $27,006 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $7,900 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $30,445 | $32,008 | $30,905 | $31,007 |
| Operating Income | -$14,393 | -$14,804 | -$14,563 | -$13,417 |
| % Margin | -66.9% | -62% | -64.6% | -56.5% |
| Other Income/Exp. Net | $564 | -$192 | $250 | $280 |
| Pre-Tax Income | -$13,829 | -$14,996 | -$14,313 | -$13,137 |
| Tax Expense | $128 | $177 | $135 | $38 |
| Net Income | -$13,957 | -$15,173 | -$14,448 | -$13,175 |
| % Margin | -64.9% | -63.6% | -64.1% | -55.4% |
| EPS | -0.34 | -0.38 | -0.36 | -0.33 |
| % Growth | 10.5% | -5.6% | -9.1% | – |
| EPS Diluted | -0.34 | -0.38 | -0.36 | -0.33 |
| Weighted Avg Shares Out | 40,937 | 40,193 | 39,955 | 39,111 |
| Weighted Avg Shares Out Dil | 40,937 | 40,193 | 39,955 | 39,111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $611 | $723 | $864 | $1,045 |
| Interest Expense | $805 | $799 | $781 | $842 |
| Depreciation & Amortization | $246 | $299 | $531 | $294 |
| EBITDA | -$12,778 | -$13,898 | -$14,563 | -$13,123 |
| % Margin | -59.4% | -58.3% | -64.6% | -55.2% |